NASDAQ:FLGT - Fulgent Genetics Stock Price, Price Target & More

$4.00 0.00 (0.00 %)
(As of 04/26/2018 08:00 AM ET)
Previous Close$4.00
Today's Range$3.98 - $4.00
52-Week Range$2.72 - $10.83
Volume1,931 shs
Average Volume9,639 shs
Market Capitalization$71.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.29

About Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics logoFulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Debt-to-Equity RatioN/A
Current Ratio10.97%
Quick Ratio10.97%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.73 million
Price / Sales3.82
Cash Flow$0.0035 per share
Price / Cash1,131.61
Book Value$3.04 per share
Price / Book1.32

Profitability

EPS (Most Recent Fiscal Year)($0.11)
Net Income$-2,510,000.00
Net Margins-14.21%
Return on Equity-4.05%
Return on Assets-3.83%

Miscellaneous

Employees98
Outstanding Shares17,880,000

How to Become a New Pot Stock Millionaire

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics (NASDAQ:FLGT) released its earnings results on Wednesday, February, 28th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The firm had revenue of $4.28 million for the quarter, compared to the consensus estimate of $5.26 million. Fulgent Genetics had a negative return on equity of 4.05% and a negative net margin of 14.21%. View Fulgent Genetics' Earnings History.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Monday, May, 14th 2018. View Earnings Estimates for Fulgent Genetics.

What price target have analysts set for FLGT?

2 analysts have issued 1 year target prices for Fulgent Genetics' shares. Their forecasts range from $6.00 to $7.00. On average, they anticipate Fulgent Genetics' share price to reach $6.50 in the next year. View Analyst Ratings for Fulgent Genetics.

Who are some of Fulgent Genetics' key competitors?

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:
  • Mr. Ming Hsieh, Chairman, Chief Exec. Officer, Pres and Mang. of Fulgent LLC (Age 62)
  • Mr. Paul Kim, Chief Financial Officer (Age 51)
  • Dr. Han Lin Gao M.D., Ph.D., D.A.B.M.G., F.A.C.M.G., Chief Scientific Officer and Lab Director (Age 51)
  • Joe Roach, VP

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

Has Fulgent Genetics been receiving favorable news coverage?

Headlines about FLGT stock have been trending positive recently, Accern reports. The research group rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fulgent Genetics earned a news sentiment score of 0.46 on Accern's scale. They also gave media coverage about the company an impact score of 45.01 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $4.00.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $71.51 million and generates $18.73 million in revenue each year. The company earns $-2,510,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Fulgent Genetics employs 98 workers across the globe.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (FLGT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  214
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fulgent Genetics (NASDAQ:FLGT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Fulgent Genetics in the last 12 months. Their average twelve-month price target is $6.50, suggesting that the stock has a possible upside of 62.50%. The high price target for FLGT is $7.00 and the low price target for FLGT is $6.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.503.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.50$6.50$7.25$8.50
Price Target Upside: 62.50% upside35.70% upside79.01% upside126.67% upside

Fulgent Genetics (NASDAQ:FLGT) Consensus Price Target History

Price Target History for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ:FLGT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/1/2018Credit Suisse GroupLower Price TargetOutperform -> Outperform$6.50 -> $6.00HighView Rating Details
3/1/2018Piper JaffrayDowngradeOverweight -> NeutralHighView Rating Details
11/7/2017Raymond JamesDowngradeOutperform -> Mkt PerformN/AView Rating Details
10/24/2016BTIG ResearchInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Fulgent Genetics (NASDAQ:FLGT) Earnings History and Estimates Chart

Earnings by Quarter for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ FLGT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/14/2018        
2/28/2018Q4 2017($0.03)($0.09)$5.26 million$4.28 millionViewN/AView Earnings Details
11/6/2017Q3 2017($0.05)$5.52 million$4.50 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.0160$0.02$5.03 million$4.64 millionViewListenView Earnings Details
5/8/2017Q1 2017$0.03$0.02$5.85 million$5.31 millionViewListenView Earnings Details
2/27/2017Q416$0.04$0.05$5.99 million$5.85 millionViewListenView Earnings Details
11/14/2016Q3 2016$0.08($0.44)$5.16 million$5.01 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Fulgent Genetics (NASDAQ:FLGT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Fulgent Genetics (NASDAQ FLGT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 58.80%
Institutional Ownership Percentage: 7.92%
Insider Trading History for Fulgent Genetics (NASDAQ:FLGT)
Institutional Ownership by Quarter for Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ FLGT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2018Paul KimCFOSell1,628$3.76$6,121.28385,401View SEC Filing  
11/30/2017Ming HsiehInsiderBuy2,000$3.60$7,200.006,549,707View SEC Filing  
11/20/2017Ming HsiehCEOBuy7,259$3.28$23,809.526,540,849View SEC Filing  
11/16/2017Ming HsiehInsiderBuy2,205$3.23$7,122.156,540,849View SEC Filing  
11/14/2017Ming HsiehInsiderBuy10,504$3.30$34,663.20View SEC Filing  
11/13/2017Paul KimCFOSell1,573$3.22$5,065.06View SEC Filing  
11/9/2017Ming HsiehCEOBuy11,520$3.47$39,974.406,506,464View SEC Filing  
8/11/2017Paul KimCFOSell6,134$5.71$35,025.14388,602View SEC Filing  
6/15/2017Ming HsiehInsiderBuy20,000$5.26$105,200.006,482,244View SEC Filing  
6/13/2017Ming HsiehInsiderBuy30,000$4.98$149,400.006,459,944View SEC Filing  
9/30/2016Ming HsiehInsiderBuy1,000,000$9.00$9,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fulgent Genetics (NASDAQ FLGT) News Headlines

Source:
DateHeadline
OpGen (OPGN) and Fulgent Genetics (FLGT) Financial ComparisonOpGen (OPGN) and Fulgent Genetics (FLGT) Financial Comparison
www.americanbankingnews.com - April 25 at 1:26 PM
Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
finance.yahoo.com - April 23 at 10:09 AM
Fulgent Genetics (FLGT) vs. Quest Diagnostics (DGX) Critical SurveyFulgent Genetics (FLGT) vs. Quest Diagnostics (DGX) Critical Survey
www.americanbankingnews.com - April 20 at 3:28 AM
Zacks: Analysts Set $4.35 Price Target for Fulgent Genetics (FLGT)Zacks: Analysts Set $4.35 Price Target for Fulgent Genetics (FLGT)
www.americanbankingnews.com - April 17 at 1:32 AM
Fulgent Genetics (FLGT) Stock Rating Lowered by Zacks Investment ResearchFulgent Genetics (FLGT) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 10 at 5:02 PM
Fulgent Genetics (FLGT) Lifted to Hold at ValuEngineFulgent Genetics (FLGT) Lifted to Hold at ValuEngine
www.americanbankingnews.com - April 8 at 12:30 PM
 Analysts Set $4.35 Target Price for Fulgent Genetics (FLGT) Analysts Set $4.35 Target Price for Fulgent Genetics (FLGT)
www.americanbankingnews.com - April 2 at 9:16 PM
 Fulgent Genetics (FLGT) Receives Average Rating of "Hold" from Brokerages Fulgent Genetics (FLGT) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - March 30 at 9:04 AM
Fulgent Genetics (FLGT) Upgraded by Zacks Investment Research to "Hold"Fulgent Genetics (FLGT) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 29 at 8:30 PM
Fulgent Genetics (FLGT) Cut to "Neutral" at Piper Jaffray CompaniesFulgent Genetics (FLGT) Cut to "Neutral" at Piper Jaffray Companies
www.americanbankingnews.com - March 24 at 2:13 PM
Edited Transcript of FLGT earnings conference call or presentation 28-Feb-18 9:30pm GMTEdited Transcript of FLGT earnings conference call or presentation 28-Feb-18 9:30pm GMT
finance.yahoo.com - March 18 at 10:32 AM
 Analysts Set $4.35 Target Price for Fulgent Genetics Inc (FLGT) Analysts Set $4.35 Target Price for Fulgent Genetics Inc (FLGT)
www.americanbankingnews.com - March 14 at 7:21 PM
Fulgent Genetics (FLGT) PT Lowered to $6.00 at Credit Suisse GroupFulgent Genetics (FLGT) PT Lowered to $6.00 at Credit Suisse Group
www.americanbankingnews.com - March 1 at 2:02 PM
Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial ResultsFulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 1 at 10:15 AM
Fulgent Genetics (FLGT) Posts Quarterly  Earnings ResultsFulgent Genetics (FLGT) Posts Quarterly Earnings Results
www.americanbankingnews.com - February 28 at 7:36 PM
Brokerages Expect Fulgent Genetics Inc (FLGT) to Announce ($0.02) EPSBrokerages Expect Fulgent Genetics Inc (FLGT) to Announce ($0.02) EPS
www.americanbankingnews.com - February 27 at 1:24 PM
Derma Sciences (DSCI) versus Fulgent Genetics (FLGT) Critical ReviewDerma Sciences (DSCI) versus Fulgent Genetics (FLGT) Critical Review
www.americanbankingnews.com - February 24 at 11:18 PM
Zacks: Fulgent Genetics Inc (FLGT) Receives Average Recommendation of "Buy" from BrokeragesZacks: Fulgent Genetics Inc (FLGT) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 24 at 3:38 PM
Representatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare ConferenceRepresentatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare Conference
finance.yahoo.com - February 23 at 10:37 AM
Zacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by BrokeragesZacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 21 at 9:24 PM
Fulgent Genetics (FLGT) to Release Quarterly Earnings on WednesdayFulgent Genetics (FLGT) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 21 at 4:46 AM
 Fulgent Genetics Inc (FLGT) Receives Consensus Recommendation of "Buy" from Analysts Fulgent Genetics Inc (FLGT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 18 at 5:10 AM
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
finance.yahoo.com - February 13 at 3:19 PM
Zacks: Fulgent Genetics Inc (FLGT) Receives Average Recommendation of "Buy" from AnalystsZacks: Fulgent Genetics Inc (FLGT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 9 at 9:10 PM
Analysts Anticipate Fulgent Genetics Inc (FLGT) to Announce ($0.02) Earnings Per ShareAnalysts Anticipate Fulgent Genetics Inc (FLGT) to Announce ($0.02) Earnings Per Share
www.americanbankingnews.com - February 6 at 11:00 AM
 Brokerages Set $7.00 Target Price for Fulgent Genetics Inc (FLGT) Brokerages Set $7.00 Target Price for Fulgent Genetics Inc (FLGT)
www.americanbankingnews.com - January 21 at 5:46 AM
Zacks: Fulgent Genetics Inc (FLGT) Receives Average Rating of "Buy" from BrokeragesZacks: Fulgent Genetics Inc (FLGT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 5 at 5:32 PM
 Fulgent Genetics Inc (FLGT) Given Consensus Rating of "Buy" by Brokerages Fulgent Genetics Inc (FLGT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 2 at 9:10 PM
Comparing Nanosphere (NSPH) & Fulgent Genetics (FLGT)Comparing Nanosphere (NSPH) & Fulgent Genetics (FLGT)
www.americanbankingnews.com - December 26 at 8:01 PM
ETFs with exposure to Fulgent Genetics, Inc. : December 26, 2017ETFs with exposure to Fulgent Genetics, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 1:50 PM
Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017Fulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017
finance.yahoo.com - December 23 at 6:11 AM
Zacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by AnalystsZacks: Fulgent Genetics Inc (FLGT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 16 at 1:52 AM
 Brokerages Set $7.00 Price Target for Fulgent Genetic (FLGT) Brokerages Set $7.00 Price Target for Fulgent Genetic (FLGT)
www.americanbankingnews.com - December 1 at 3:48 PM
Analyzing Fulgent Genetic (FLGT) & InVivo Therapeutics (NVIV)Analyzing Fulgent Genetic (FLGT) & InVivo Therapeutics (NVIV)
www.americanbankingnews.com - November 26 at 9:24 AM
Reviewing ViewRay (VRAY) and Fulgent Genetic (FLGT)Reviewing ViewRay (VRAY) and Fulgent Genetic (FLGT)
www.americanbankingnews.com - November 24 at 5:12 PM
Ming Hsieh Purchases 7,259 Shares of Fulgent Genetic (FLGT) StockMing Hsieh Purchases 7,259 Shares of Fulgent Genetic (FLGT) Stock
www.americanbankingnews.com - November 21 at 4:40 PM
 Fulgent Genetic (FLGT) Given $7.00 Average Target Price by Analysts Fulgent Genetic (FLGT) Given $7.00 Average Target Price by Analysts
www.americanbankingnews.com - November 16 at 3:52 PM
Fulgent Genetic (FLGT) Insider Acquires $34,663.20 in StockFulgent Genetic (FLGT) Insider Acquires $34,663.20 in Stock
www.americanbankingnews.com - November 15 at 9:32 PM
Fulgent Genetic (FLGT) Downgraded by Zacks Investment ResearchFulgent Genetic (FLGT) Downgraded by Zacks Investment Research
www.americanbankingnews.com - November 13 at 7:08 PM
Fulgent Genetic (FLGT) CEO Buys $39,974.40 in StockFulgent Genetic (FLGT) CEO Buys $39,974.40 in Stock
www.americanbankingnews.com - November 13 at 6:54 PM
Analyzing Digirad Corporation (DRAD) and Fulgent Genetic (FLGT)Analyzing Digirad Corporation (DRAD) and Fulgent Genetic (FLGT)
www.americanbankingnews.com - November 10 at 5:48 PM
Edited Transcript of FLGT earnings conference call or presentation 6-Nov-17 10:00pm GMTEdited Transcript of FLGT earnings conference call or presentation 6-Nov-17 10:00pm GMT
finance.yahoo.com - November 8 at 6:56 AM
Fulgent Genetic (FLGT) Price Target Cut to $7.50 by Analysts at Credit Suisse GroupFulgent Genetic (FLGT) Price Target Cut to $7.50 by Analysts at Credit Suisse Group
www.americanbankingnews.com - November 7 at 10:28 PM
Fulgent Genetic (FLGT) Downgraded by Raymond James Financial, Inc.Fulgent Genetic (FLGT) Downgraded by Raymond James Financial, Inc.
www.americanbankingnews.com - November 7 at 11:33 AM
Fulgent Genetic (FLGT) Issues Quarterly  Earnings ResultsFulgent Genetic (FLGT) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 6 at 10:50 PM
Fulgent Geneticss (FLGT) CEO Ming Hsieh on Q3 2017 Results - Earnings Call TranscriptFulgent Genetics's (FLGT) CEO Ming Hsieh on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 10:38 PM
Fulgent Genetics, Inc. to Host Earnings CallFulgent Genetics, Inc. to Host Earnings Call
finance.yahoo.com - November 6 at 10:38 PM
Fulgent Genetics Reports Third Quarter 2017 Financial ResultsFulgent Genetics Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 6 at 10:38 PM
Fulgent Genetic (FLGT) to Release Earnings on MondayFulgent Genetic (FLGT) to Release Earnings on Monday
www.americanbankingnews.com - October 30 at 1:00 PM
Financial Comparison: GenMark Diagnostics (GNMK) & FULGENT GENETIC (FLGT)Financial Comparison: GenMark Diagnostics (GNMK) & FULGENT GENETIC (FLGT)
www.americanbankingnews.com - October 30 at 5:16 AM

SEC Filings

Fulgent Genetics (NASDAQ:FLGT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fulgent Genetics (NASDAQ:FLGT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fulgent Genetics (NASDAQ FLGT) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.